Skip to main content
logo
Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
5.92
+0.06 (1.02%)
Oct 20, 2026, 4:00 PM EDT - Market closed

Profound Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
217285225202223234
Market Cap Growth
30.33%26.48%11.58%-9.56%-4.57%-41.98%
Enterprise Value
185265206176178163
Last Close Price
5.927.877.518.4910.8911.23

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.3517.7121.1028.0633.4334.05
PB Ratio
4.354.293.736.474.302.90
P/TBV Ratio
4.364.303.756.574.353.06

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.7116.4419.2724.4326.5823.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.070.090.250.160.02
Net Debt / Equity Ratio
-0.62-0.83-0.82-0.59-0.74-0.82
Net Debt / EBITDA Ratio
0.891.351.550.661.332.22
Net Debt / FCF Ratio
0.851.432.120.811.482.94
Asset Turnover
0.340.220.190.130.090.07
Inventory Turnover
0.570.670.570.390.480.62
Quick Ratio
5.2611.029.445.2612.6316.50
Current Ratio
6.4612.5310.526.5814.8218.56
Return on Equity (ROE)
-73.53%-67.12%-60.70%-68.06%-43.23%-34.50%
Return on Assets (ROA)
-39.46%-34.91%-36.19%-33.05%-24.47%-19.79%
Return on Capital Employed (ROCE)
-66.40%-57.80%-51.90%-76.20%-49.10%-36.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.12%-14.93%-12.34%-14.02%-12.84%-13.12%
FCF Yield
-16.75%-13.46%-10.41%-11.19%-11.55%-9.57%
Buyback Yield / Dilution
-20.87%-22.08%-16.91%-1.69%-1.79%-18.33%
SEC Filings: 10-K · 10-Q